ZEINAB HARB: Open Payments
NPI 1790450344 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 44 payments from 20 companies in 2025. Trend: 2023 $581 · 2024 $847 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $149 |
| PFIZER INC. | 5 | $82 |
| Ardelyx, Inc. | 5 | $73 |
| Lilly USA, LLC | 4 | $65 |
| Viatris Specialty LLC | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Exact Sciences Corporation | 2 | $37 |
| ABBVIE INC. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
Products named: IBSRELA, NURTEC ODT, JARDIANCE, YUPELRI, CAPLYTA, Cologuard Collection Kit, Wegovy, XIFAXAN.
Industry payments across MI — which companies pay providers there.
